Thomas Struengmann & family

$9.18B

as of 07/05/24

About Thomas Struengmann & family

Thomas Struengmann and twin brother Andreas were early backers of German firm BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.

The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.

The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.

In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.

Personal stats

Citizenship

Germany

Source of wealth

Pharmaceuticals

Residence

Tegernsee, Germany

Marital status

Married

Birth date

02/16/50 (age 74)

Number of children

Education

Master of Business Administration, University of Augsburg; Master of Business Administration, University of Augsburg

Self-made

self-made